Opexa Therapeutics, Inc.·4

May 18, 6:34 PM ET

Opexa Therapeutics, Inc. 4

4 · Opexa Therapeutics, Inc. · Filed May 18, 2016

Insider Transaction Report

Form 4
Period: 2016-05-16
Transactions
  • Award

    Common Stock

    2016-05-16+6,45517,079 total
Holdings
  • Common Stock

    (indirect: see footnote)
    129,676
Footnotes (1)
  • [F1](1) Held by Alkek and Williams Ventures, Ltd. ("Ventures"). Chaswil, Ltd. ("Chaswil") is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and/or investment power with respect to the Issuer securities held by Ventures. Mr. Seaman disclaims beneficial ownership of the shares held by Ventures except to the extent of any pecuniary interest therein.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT